Extragenital lichen sclerosus and atrophicus treated with topical steroids and retinoids in a child with vitiligo

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 3, 2008, Pages 757-759

  Guerriero, C ^a   Manco, Simona ^a   Paradisi, A ^a   Capizzi, R ^a   Fossati, B ^a   Fabrizi, G ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

Extragenital lichen sclerosus; Retinoids; Steroids; Vitiligo

Indexed keywords

CLOBETASOL PROPIONATE; RETINAL; RETINOID DERIVATIVE; STEROID;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; SCHOOL CHILD; SCLERODERMA; SKIN ATROPHY; SKIN BIOPSY; TREATMENT DURATION; VITILIGO;

EID: 53749103877     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100333     Document Type: Article

References (13)

1. Meyrick TRH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J Roy Soc Med 1996; 89:694-698.
2. Wallace HJ. Lichen sclerosus et atrophicus. Trans Rep ST John's Hospital Dermatol Soc 1971; 57:9-30.
3. Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004; 17:28-37.
4. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777-83.
5. Carlson JA, Grabowski R, Mu XC, et al. Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol 2002; 24:97-107.
6. Ruiz Maldonado R, Orozco-Covarrubias ML. Post-inflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg 1997; 16:36-43.
7. Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ. Interleukins 1 alpha and 6 and tumor necrosis factor alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J invest Dermatol 1991; 96:80-5.
8. Meyrick Thomas RH, Ridley CM, Mc Gibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol 1988; 118:41-6.
9. Lorenz B, Kautman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998; 43:790-4.
10. Virgili A, Corazza M, Bianchi A, et al. Open study of topical 0.025% tretinoin in the treatment of vulval lichen sclerosus. One year of therapy. J Reprod Med 1995; 40:614-18.
11. Kaya G, Saurat JH. Restored epidermal CD44 expression in lichen sclerosus et atrophicus and clinical improvement with topical application of retinaldehyde. Br J Dermatol 2005; 152:565-595.
12. Kaja G, Augsburger E, Stamenkovic I, Saurat JH. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J Invest Dermatol 2000; 115: 1054-1058.
13. Lesnik RH, Mezick JA, Capetola R, Kligman LH. Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. J Am Acad Dermatol 1989; 21:186-90.